Health : Medical Research (Fundraising)

Cancer Research Institute

The Leader in Immunotherapy

four stars

94.69

One Exchange Plaza 55 Broadway, Suite 1802
New York, NY 10006
tel: (800) 992-2623   Web Site
EIN: 13-1837442

Board Leadership
Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO
Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs

  Score
(out of 100)
Rating
Overall Score & Rating 94.69 four stars
  Financial 92.50 four stars
  Accountability & Transparency 100.00 four stars
This rating was published 06/01/2016 and includes data from FY2015, the most recent 990 received at that time.

Learn more about how we calculate the overall score and rating.

Financial

four stars

92.50

Accountability & Transparency

four stars

100.00

This rating was published 06/01/2016 and includes data from FY2015, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity’s total expenses spent on the programs
and services it delivers)
85.7%
  Administrative Expenses 5.0%
  Fundraising Expenses 9.1%
  Fundraising Efficiency $0.09
  Working Capital Ratio (years) 1.49
  Program Expenses Growth 35.8%
  Liabilities to Assets 53.3%
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Cancer Research Institute on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $22,276,932
   Federated Campaigns $427,819
   Membership Dues $0
   Fundraising Events $4,298,057
   Related Organizations $0
   Government Grants $0
Total Contributions $27,002,808
   Program Service Revenue $0
Total Primary Revenue $27,002,808
   Other Revenue $720,352
TOTAL REVENUE $27,723,160
   
EXPENSES (Adjusted)  
   Program Expenses $33,421,070
   Administrative Expenses $1,425,239
   Fundraising Expenses $3,886,103
TOTAL FUNCTIONAL EXPENSES $38,732,412
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-11,009,252
   
Net Assets $44,949,852

Charts

Compensation % of Expenses Paid to Title
$388,774 1.00% Jill O'Donnell-Tormey CEO

Mission

Save more lives by fueling the discovery and development
of powerful immunotherapies for all types of cancer.

Established in 1953, the Cancer Research Institute (CRI) is the world's only nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers. We fund the most innovative research by young scientists, invest in clinical studies of promising new treatments, and serve as a bridge between the lab and the clinic. CRI has invested $311 million to fund more than 3,000 scientists all over the world. With more than 60 years of experience funding research on the immune system and cancer, CRI is leading the way and ushering in a new era when patients with all types of cancer can be treated and cured with immunotherapy.

Highly Rated

Charity Name & State Overall Score Overall Rating
Cancer Research Institute (NY) 94.69 four stars
A Kids' Brain Tumor Cure (NY) 97.74 four stars
Breast Cancer Research Foundation (NY) 91.16 four stars
The THANC Foundation (NY) 89.10 three stars
Pediatric Cancer Research Foundation (CA) 90.56 four stars

Compare These Charities (Highly Rated)

Charity Contact Info

Cancer Research Institute
One Exchange Plaza
55 Broadway, Suite 1802
New York, NY 10006
tel: (800) 992-2623
fax: (212) 832-9376
EIN: 13-1837442

Visit Web Site

Board Leadership

Paul C. Shiverick and Andrew K. Tsai
Chairmen

CEO

Jill O'Donnell-Tormey
Chief Executive Officer & Director of Scientific Affairs